Sep 4, 2025, 08:50
Monoclonal Antibodies and Heparin-Induced Thrombocytopenia: NEJM Article Shared by Uriel Suárez
Uriel Suárez, Hematologist at Fundación Jiménez Díaz, has shared a post on X:
“Monoclonal Antibodies in the Pathogenesis of Heparin-Induced Thrombocytopenia | New England Journal of Medicine”
Title: Monoclonal Antibodies in the Pathogenesis of Heparin-Induced Thrombocytopenia
Authors: Jared Treverton, Donald M. Arnold, Daniil G. Ivanov, Nikola Ivetic, Yi Zhang, Hossam A. Ali, Rumi Clare, Igor A. Kaltashov, John G. Kelton, Ishac Nazy
Read the full article here.
Read Hemostasis Today, stay updated on scientific advances in the field of hemostasis.
-
Mar 6, 2026, 16:51Priya Reehal: Highlighting The Central Role of Nurses in Cardio-Oncology
-
Mar 6, 2026, 16:50Rainer Kaiser: Blinatumomab Shows Remarkable Response in Multi-Refractory ITP and APS
-
Mar 6, 2026, 16:18Laila Shalabi: Clopidogrel, Aspirin, and the Role of PPIs in Coronary Artery Disease
-
Mar 6, 2026, 16:17Paul McKenzie: The Value of Gene Therapy in Bleeding Disorders
-
Mar 6, 2026, 16:15Basma El Homasany: The ‘Little Brain’ of the Heart and Its Role in Health
-
Mar 6, 2026, 16:14Jamal Rana: Family History and Polygenic Risk for Coronary Heart Disease
-
Mar 6, 2026, 15:43Kristy Ainslie: Breaking Down the Discovery and FDA Approval of Drug Carriers
-
Mar 6, 2026, 15:18Claudio Laudani: Efficacy and Safety of Colchicine for Secondary Prevention in Coronary Artery Disease
-
Mar 6, 2026, 15:09Chris Simon: Persona PLUS Receives FDA Clearance for Patent‑Protected Plasma Apheresis